Supratentorial Neoplasms Completed Phase 4 Trials for Remifentanil (DB00899)

Also known as: Neoplasm, Supratentorial

IndicationStatusPhase
DBCOND0032373 (Supratentorial Neoplasms)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02593942Remifentanil Infusion Alone During the Closure Period for Early Emergence Following CraniotomyPrevention